ECP as prognostic Marker for Melanoma

被引：0
|
作者：
Moreira, A. [1 ]
Krueckel, A. [1 ]
Schuler, G. [1 ]
Utikal, J. [2 ]
Heinzerling, L. [1 ]
机构：
[1] Univ Klinikum Erlangen, Hautklin, Erlangen, Germany
[2] Univ Med Mannheim, Mannheim, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2019年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P08
引用
收藏
页码：27 / 28
页数：2
相关论文
共 50 条
  • [41] Mutation burden as a potential prognostic marker of melanoma progression and survival.
    Simpson, Danny
    Ferguson, Robert
    Martinez, Carlos N.
    Kazlow, Esther
    Moran, Una
    Heguy, Adriana
    Hanniford, Douglas
    Hernando, Eva
    Osman, Iman
    Kirchhoff, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker, Maria R.
    Siegelin, Markus D.
    Rompel, Rainer
    Enk, Alexander H.
    Gaiser, Timo
    MELANOMA RESEARCH, 2009, 19 (01) : 8 - 16
  • [43] BAP1 methylation: a prognostic marker of uveal melanoma metastasis
    Bakhoum, Mathieu F.
    Curtis, Ellis J.
    Goldbaum, Michael H.
    Mischel, Paul S.
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [44] CRD-BP as a potential prognostic marker and therapeutic target in melanoma
    Xu, Y. G.
    Kim, T.
    Setaluri, V.
    Spiegelman, V.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S110 - S110
  • [45] Circulating tumor DNA mutation as a prognostic marker in melanoma with brain metastasis.
    Behera, Tapas Ranjan
    Song, Jung Min
    Eicher, Donald Matthew
    Gastman, Brian
    Farkas, Daniel H.
    Funchain, Pauline
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma
    Bezrookove, Vladimir
    Nosrati, Mehdi
    Miller, James R., III
    De Semir, David
    Dar, Altaf A.
    Vosoughi, Elham
    Vaguero, Edith
    Sucker, Antje
    Lazar, Alexander J.
    Gershenwald, Jeffrey E.
    Davies, Michael A.
    Schadendorf, Dirk
    Kashani-Sabet, Mohammed
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4119 - 4125
  • [47] Hu antigen R (HuR) heterogeneous expression quantification as a prognostic marker of melanoma
    Liaudet, Nicolas
    Fernandez, Marylise
    Fontao, Lionel
    Kaya, Gurkan
    Merat, Rastine
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (05) : 333 - 336
  • [48] The novel prognostic marker SPOCK2 regulates tumour progression in melanoma
    Kang, Ji Young
    Cho, Hyeijin
    Gil, Minchan
    Lee, Haeryung
    Park, Soochul
    Kim, Kyung Eun
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (06)
  • [49] TRIM16 is a prognostic marker for patients with lymph node metastatic melanoma
    Cheung, Belamy B.
    Sutton, Selina K.
    Tan, Owen
    Koach, Jessica
    Liu, Bing
    Liu, Tao
    Scolyer, Richard A.
    Zhang, Xu Dong
    Marshall, Glenn M.
    CANCER RESEARCH, 2013, 73 (08)
  • [50] Prognostic and Immunotherapeutic Value of Regulatory T Cell Marker Gene Signature in Melanoma
    Liu, Yurong
    Liu, Jianlan
    Jiang, Keyu
    Cheng, Xiaolong
    Di, Sitong
    Tang, Jian
    Luo, Binlin
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2025, 24 (02) : 237 - 253
12345